Navigation Links
Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:4/26/2008

First Large Study Comparing Leading Hepatitis C Therapies Provides

Important Insights to Help Guide Clinical Practice

MILAN, Italy, April 26 /PRNewswire-FirstCall/ -- Final results of the IDEAL study, the first large, randomized, clinical study comparing the leading therapies for chronic hepatitis C, were presented today at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), providing important insights that may help guide clinical practice for physicians worldwide treating this serious and potentially life-threatening disease.

The IDEAL study compared combination therapy with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) vs. Pegasys (peginterferon alfa-2a) and Copegus (ribavirin, USP),(1) as well as a lower dose of PEGINTRON in an investigational combination with REBETOL. The results showed that sustained virologic response (SVR),(2) the primary endpoint of the study, was similar for all three treatment regimens. The study also showed in secondary analyses that PEGINTRON combination therapy provided greater predictability of response at important treatment milestones and significantly lower relapse rates after the end of treatment than Pegasys and Copegus combination therapy, despite patients in the Pegasys arm overall receiving a significantly higher median ribavirin dose over the duration of the study. Safety and tolerability were similar among the treatment arms.

"IDEAL provides important insights about the similarities and differences of the two leading combination therapies for hepatitis C, and how physicians can use these findings to help manage their patients," said Robert J. Spiegel, M.D., chief medical officer and senior vice president, Schering-Plough Research Institute.

In IDEAL (Individualized Dosing Efficacy vs. flat dosing to assess optimaL pegylated interferon therapy), 3,070 previously untreated U.S. patients with HCV genotype 1, the most co
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
3. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
4. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
11. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... --  DaVita HealthCare Partners Inc. (NYSE: ... and most innovative health care communities, today announced ... 37 th overall in its global rankings, ... Business Review (HBR). The ... on reputation strength, considers seven key areas when ...
(Date:10/16/2014)... Oct. 16, 2014 Eight finalists, all representing ... to present their proposals for a chance to compete ... Sheikh Zayed Institute Second Annual Pediatric Surgical Innovation ... on Friday, Oct. 24, 2014. Selected ... across the US and internationally, the finalists are: ...
(Date:10/16/2014)... BETHESDA, Md. , Oct. 16, 2014 ... the completion of guidance on the application ... manufacturing operations for pharmaceutical and biopharmaceutical products ... No. 66: Application of Single-Use ... Single-use technology, often described as single-use systems ...
Breaking Medicine Technology:Harvard Business Review Recognizes DaVita HealthCare Partners 2Harvard Business Review Recognizes DaVita HealthCare Partners 3Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4PDA Offers Help in Applying Single-Use Systems to Bio/Pharma Operations 2
... Massachusetts, September 14, 2010 ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... Sept. 14 Palmetto Health Richland in Columbia—South ... Masimo (Nasdaq: MASI ) ... Masimo Patient SafetyNet, an advanced remote monitoring and ... early clinical response, preempt sentinel events, and avoid ...
Cached Medicine Technology:Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 2Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 3Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 4Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 5Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 6Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 7Elsevier Appoints Suzanne BeDell as Managing Director, Science and Technology (S&T) Books 8Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System 2Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System 3Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System 4Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System 5Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System 6
(Date:10/19/2014)... 20, 2014 Hastings and Hastings, a ... of service throughout the greater Phoenix area and across ... with regard to catastrophic automobile accidents. Statistics have indicated ... and throughout Arizona. As such, Hastings and Hastings has ... representation for those who have been injured through no ...
(Date:10/19/2014)... 2014 Dr. Babatunde Osotimehin, Executive Director ... of a ceasefire agreement that is expected to lead ... who were kidnapped from the north-eastern Nigerian town of ... long enough, and it is high time they are ... Osotimehin. , "We owe it to these girls to ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its ... GoDaddy and HostMonster are the best VPS hosting ... Server) is the method of partitioning a physical ... has the appearance and capabilities of running on ... site pays close attention to VPS products and ...
(Date:10/19/2014)... Visual Impact Frequency Training - a ... to the public generating a frenzied buzz of ... community. The commotion surrounding the program's launch has ... an investigative review. , "Many gym-goers are familiar ... known as a training 'plateau' where they are ...
(Date:10/19/2014)... spondylitis is a systemic disease that causes inflammation ... have affected members of the ancient Egyptian royal ... Arthritis & Rheumatology , a journal of the ... finding instead a degenerative spinal condition called diffuse ... from the 18th to early 20th Dynasties. ...
Breaking Medicine News(10 mins):Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
... 5 Nine out of 10 women in,the United ... partner,experiences symptoms like fatigue, depressed mood and increased waistline ... testosterone, or Low T, according,to survey results announced today ... their husbands or boyfriends about making their health a,priority ...
... Jan. 5 Dental Network of America (DNoA) ... Philips Electronics North America Corporation (Philips), just signed ... to offer its "DNoA Preferred Network" dentists in ... discounts on their Sonicare(TM) product line."Partnering with Philips ...
... to reflexology and aromatherapy, as part of chair massage treatments in ... back the anecdotal evidence from stressful offices around the US. ... ... and Aromatherapy increase the positive impacts of chair massage in the ...
... Direct Nutritionals, LLC,the exclusive worldwide distributor of the ... loss system and hunger-controlling diet cookies and diet,shake ... completely redesigned,version of its web site with many ... http://www.CookieDiet.com ). Since its launch in ...
... a slowdown in several types of mental processing, which appears ... to new research. Given the sharp rise in new cases ... be living with mild but lasting deficits in their thought ... of Neuropsychology , which is published by the American ...
... , , SATURDAY, Jan. 3 (HealthDay News) -- If a ... week, you may have sinusitis, which often results from ... Americans develop sinusitis, which results in 18 million physician ... to the American Academy of Allergy, Asthma & Immunology. ...
Cached Medicine News:Health News:New Initiative Urges Women to Address Men's Health this New Year 2Health News:New Initiative Urges Women to Address Men's Health this New Year 3Health News:New Initiative Urges Women to Address Men's Health this New Year 4Health News:New Initiative Urges Women to Address Men's Health this New Year 5Health News:Dental Network of America and Philips Sign Agreement to Offer Sonicare Products to Dental Providers 2Health News:Workplace Creativity Activated by Reflexology, Chair Massage 2Health News:Workplace Creativity Activated by Reflexology, Chair Massage 3Health News:CookieDiet.com, the 100% New Dr. Siegal's COOKIE DIET Web Site, Debuts with Weight Loss Calculators and Worldwide Shipping 2Health News:CookieDiet.com, the 100% New Dr. Siegal's COOKIE DIET Web Site, Debuts with Weight Loss Calculators and Worldwide Shipping 3Health News:Adult-onset diabetes slows mental functioning in several ways, with deficits appearing early 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: